产品: 磷酸化 IKK beta (Tyr199) 抗体
货号: AF3010
描述: Rabbit polyclonal antibody to Phospho-IKK beta (Tyr199)
应用: WB IHC IF/ICC
反应: Human, Mouse, Rat, Monkey
预测: Pig, Zebrafish, Bovine, Horse, Rabbit, Dog, Xenopus
分子量: 85kDa; 87kD(Calculated).
蛋白号: O14920
RRID: AB_2834449

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1300 现货
 100ul RMB¥ 2400 现货
 200ul RMB¥ 3200 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human,Mouse,Rat,Monkey
预测:
Pig(100%), Zebrafish(92%), Bovine(100%), Horse(100%), Rabbit(100%), Dog(100%), Xenopus(92%)
克隆:
Polyclonal
特异性:
Phospho-IKK beta (Tyr199) Antibody detects endogenous levels of IKK beta only when phosphorylated at Tyrosine 199.
RRID:
AB_2834449
引用格式: Affinity Biosciences Cat# AF3010, RRID:AB_2834449.
偶联:
Unconjugated.
纯化:
The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

I kappa B kinase 2; I kappa B kinase beta; I-kappa-B kinase 2; I-kappa-B-kinase beta; IkBKB; IKK beta; IKK-B; IKK-beta; IKK2; IKKB; IKKB_HUMAN; IMD15; Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase beta; Inhibitor of nuclear factor kappa-B kinase subunit beta; NFKBIKB; Nuclear factor NF-kappa-B inhibitor kinase beta;

抗原和靶标

免疫原:
Uniprot:
基因/基因ID:
表达:
O14920 IKKB_HUMAN:

Highly expressed in heart, placenta, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis and peripheral blood.

描述:
IKK-beta is a kinase of the IKK family. Phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. Preferentially found as a heterodimer with IKK-alpha but also as an homodimer.
序列:
MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS

种属预测

种属预测:

score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。

Species
Results
Score
Pig
100
Horse
100
Bovine
100
Dog
100
Rabbit
100
Xenopus
92
Zebrafish
92
Sheep
0
Chicken
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

翻译修饰 - O14920 作为底物

Site PTM Type Enzyme
S4 Phosphorylation
S6 Phosphorylation
T23 Phosphorylation
K44 Ubiquitination
K106 Ubiquitination
K147 Ubiquitination
K163 Ubiquitination
Y169 Phosphorylation
K171 Ubiquitination
S177 Phosphorylation P54646 (PRKAA2) , PR:000035736 (hMAP3K7/Phos:1) , P17252 (PRKCA) , Q02156 (PRKCE) , O43318 (MAP3K7) , Q99558 (MAP3K14) , Q05513 (PRKCZ) , Q9UHD2 (TBK1)
C179 S-Nitrosylation
T180 Acetylation
T180 Phosphorylation
S181 Phosphorylation Q9UHD2 (TBK1) , P17252 (PRKCA) , O00141 (SGK1) , O15530 (PDPK1) , Q99558 (MAP3K14) , P54646 (PRKAA2) , Q9Y6K9 (IKBKG) , PR:000035736 (hMAP3K7/Phos:1) , O14920 (IKBKB) , O43318 (MAP3K7) , Q05513 (PRKCZ)
Y188 Phosphorylation P12931 (SRC) , P07948 (LYN)
Y199 Phosphorylation P12931 (SRC) , P07948 (LYN)
S239 Phosphorylation
S246 Phosphorylation
S256 Phosphorylation
S257 Phosphorylation
S258 Phosphorylation
Y261 Phosphorylation
S267 Phosphorylation
K301 Ubiquitination
T324 Phosphorylation
Y325 Phosphorylation
S332 Phosphorylation
S335 Phosphorylation
K337 Ubiquitination
T344 Phosphorylation
K365 Ubiquitination
T368 Phosphorylation
S393 Phosphorylation
T396 Phosphorylation
Y397 Phosphorylation
T399 Phosphorylation
S402 Phosphorylation
S409 Phosphorylation
S411 Phosphorylation
K418 Ubiquitination
K467 Ubiquitination
S471 Phosphorylation
S474 Phosphorylation
S476 Phosphorylation
T488 Phosphorylation
S489 Phosphorylation
S507 Phosphorylation
K509 Ubiquitination
S550 Phosphorylation
K555 Ubiquitination
T559 Phosphorylation
T583 Phosphorylation
S587 Phosphorylation
S600 Phosphorylation
K603 Ubiquitination
Y609 Phosphorylation
T610 Phosphorylation
K628 Ubiquitination
S634 Phosphorylation
K652 Ubiquitination
K659 Acetylation
K664 Ubiquitination
S670 Phosphorylation O14920 (IKBKB)
S672 Phosphorylation O14920 (IKBKB)
S675 Phosphorylation O14920 (IKBKB)
S679 Phosphorylation O14920 (IKBKB)
S682 Phosphorylation O14920 (IKBKB)
S689 Phosphorylation O14920 (IKBKB)
S692 Phosphorylation O14920 (IKBKB)
T693 Phosphorylation
S695 Phosphorylation O14920 (IKBKB)
S697 Phosphorylation O14920 (IKBKB)
K703 Ubiquitination
S705 Phosphorylation O14920 (IKBKB)
S733 O-Glycosylation
S733 Phosphorylation O14920 (IKBKB) , P53350 (PLK1)
T735 Phosphorylation
S740 Phosphorylation O14920 (IKBKB) , P53350 (PLK1)
S750 Phosphorylation O14920 (IKBKB) , P53350 (PLK1)
S756 Phosphorylation O14920 (IKBKB)

翻译修饰 - O14920 作为激酶

Substrate Site Source
O14920-1 (IKBKB) C179 Uniprot
O14920 (IKBKB) S181 Uniprot
O14920 (IKBKB) S670 Uniprot
O14920 (IKBKB) S672 Uniprot
O14920 (IKBKB) S675 Uniprot
O14920-1 (IKBKB) S679 Uniprot
O14920 (IKBKB) S682 Uniprot
O14920 (IKBKB) S689 Uniprot
O14920-1 (IKBKB) S692 Uniprot
O14920 (IKBKB) S695 Uniprot
O14920-1 (IKBKB) S697 Uniprot
O14920-1 (IKBKB) S705 Uniprot
O14920-1 (IKBKB) S733 Uniprot
O14920 (IKBKB) S740 Uniprot
O14920-1 (IKBKB) S750 Uniprot
O14920 (IKBKB) S756 Uniprot
O43524 (FOXO3) S644 Uniprot
O95999 (BCL10) S134 Uniprot
P01100 (FOS) S308 Uniprot
P04637 (TP53) S362 Uniprot
P04637 (TP53) S366 Uniprot
P19438 (TNFRSF1A) S381 Uniprot
P19838 (NFKB1) S923 Uniprot
P19838-2 (NFKB1) S924 Uniprot
P19838 (NFKB1) S927 Uniprot
P19838-2 (NFKB1) S928 Uniprot
P19838 (NFKB1) S932 Uniprot
P23396 (RPS3) S209 Uniprot
P25963 (NFKBIA) S32 Uniprot
P25963 (NFKBIA) S36 Uniprot
P31946 (YWHAB) S132 Uniprot
P35568 (IRS1) S268 Uniprot
P35568 (IRS1) S270 Uniprot
P35568 (IRS1) S272 Uniprot
P35568 (IRS1) S274 Uniprot
P35568 (IRS1) S307 Uniprot
P35568 (IRS1) S312 Uniprot
P35568 (IRS1) S341 Uniprot
P35568 (IRS1) S345 Uniprot
P35568 (IRS1) S527 Uniprot
P35568 (IRS1) S531 Uniprot
P42771 (CDKN2A) S8 Uniprot
Q01201 (RELB) S472 Uniprot
Q04206 (RELA) S468 Uniprot
Q04206 (RELA) S536 Uniprot
Q04864 (REL) S557 Uniprot
Q13568 (IRF5) S446 Uniprot
Q14164 (IKBKE) S172 Uniprot
Q14653 (IRF3) S396 Uniprot
Q14653 (IRF3) S398 Uniprot
Q14653 (IRF3) S402 Uniprot
Q14653 (IRF3) T404 Uniprot
Q14653 (IRF3) S405 Uniprot
Q15653 (NFKBIB) S19 Uniprot
Q15653-1 (NFKBIB) S23 Uniprot
Q16875 (PFKFB3) S269 Uniprot
Q5S007 (LRRK2) S910 Uniprot
Q5S007 (LRRK2) S935 Uniprot
Q92574 (TSC1) S487 Uniprot
Q92574 (TSC1) S511 Uniprot
Q96CV9 (OPTN) S513 Uniprot
Q99704 (DOK1) S439 Uniprot
Q99704 (DOK1) S443 Uniprot
Q99704 (DOK1) S446 Uniprot
Q99704 (DOK1) S450 Uniprot
Q9BXH1 (BBC3) S10 Uniprot
Q9H3D4 (TP63) S43 Uniprot
Q9H3D4 (TP63) S51 Uniprot
Q9NQC7 (CYLD) S418 Uniprot
Q9NQC7 (CYLD) S422 Uniprot
Q9NQC7 (CYLD) S432 Uniprot
Q9NQC7 (CYLD) S436 Uniprot
Q9NQC7 (CYLD) S439 Uniprot
Q9NQC7 (CYLD) S441 Uniprot
Q9NQC7 (CYLD) S444 Uniprot
Q9Y4G8 (RAPGEF2) S1254 Uniprot
Q9Y6K9-1 (IKBKG) S31 Uniprot
Q9Y6K9 (IKBKG) S43 Uniprot
Q9Y6K9 (IKBKG) S68 Uniprot
Q9Y6K9 (IKBKG) S85 Uniprot
Q9Y6K9-1 (IKBKG) S376 Uniprot
Q9Y6Q9-5 (NCOA3) S857 Uniprot

研究背景

功能:

Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. Acts as part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation. Phosphorylates inhibitors of NF-kappa-B on 2 critical serine residues. These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome. In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. In addition to the NF-kappa-B inhibitors, phosphorylates several other components of the signaling pathway including NEMO/IKBKG, NF-kappa-B subunits RELA and NFKB1, as well as IKK-related kinases TBK1 and IKBKE. IKK-related kinase phosphorylations may prevent the overproduction of inflammatory mediators since they exert a negative regulation on canonical IKKs. Phosphorylates FOXO3, mediating the TNF-dependent inactivation of this pro-apoptotic transcription factor. Also phosphorylates other substrates including NCOA3, BCL10 and IRS1. Within the nucleus, acts as an adapter protein for NFKBIA degradation in UV-induced NF-kappa-B activation. Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity).

翻译修饰:

Upon cytokine stimulation, phosphorylated on Ser-177 and Ser-181 by MEKK1 and/or MAP3K14/NIK as well as TBK1 and PRKCZ; which enhances activity. Once activated, autophosphorylates on the C-terminal serine cluster; which decreases activity and prevents prolonged activation of the inflammatory response. Phosphorylated by the IKK-related kinases TBK1 and IKBKE, which is associated with reduced CHUK/IKKA and IKBKB activity and NF-kappa-B-dependent gene transcription. Dephosphorylated at Ser-177 and Ser-181 by PPM1A and PPM1B.

(Microbial infection) Acetylation of Thr-180 by Yersinia yopJ prevents phosphorylation and activation, thus blocking the I-kappa-B pathway.

Ubiquitinated. Monoubiquitination involves TRIM21 that leads to inhibition of Tax-induced NF-kappa-B signaling. According to 'Ser-163' does not serve as a monoubiquitination site. According to ubiquitination on 'Ser-163' modulates phosphorylation on C-terminal serine residues.

(Microbial infection) Monoubiquitination by TRIM21 is disrupted by Yersinia yopJ.

Hydroxylated by PHD1/EGLN2, loss of hydroxylation under hypoxic conditions results in activation of NF-kappa-B.

细胞定位:

Cytoplasm. Nucleus. Membrane raft.
Note: Colocalized with DPP4 in membrane rafts.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
组织特异性:

Highly expressed in heart, placenta, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis and peripheral blood.

亚基结构:

Component of the I-kappa-B-kinase (IKK) core complex consisting of CHUK, IKBKB and IKBKG; probably four alpha/CHUK-beta/IKBKB dimers are associated with four gamma/IKBKG subunits. The IKK core complex seems to associate with regulatory or adapter proteins to form a IKK-signalosome holo-complex. The IKK complex associates with TERF2IP/RAP1, leading to promote IKK-mediated phosphorylation of RELA/p65 (By similarity). Part of a complex composed of NCOA2, NCOA3, CHUK/IKKA, IKBKB, IKBKG and CREBBP. Part of a 70-90 kDa complex at least consisting of CHUK/IKKA, IKBKB, NFKBIA, RELA, ELP1 and MAP3K14. Found in a membrane raft complex, at least composed of BCL10, CARD11, DPP4 and IKBKB. Interacts with SQSTM1 through PRKCZ or PRKCI. Forms an NGF-induced complex with IKBKB, PRKCI and TRAF6 (By similarity). May interact with MAVS/IPS1. Interacts with NALP2. Interacts with TICAM1. Interacts with FAF1; the interaction disrupts the IKK complex formation. Interacts with ATM. Part of a ternary complex consisting of TANK, IKBKB and IKBKG. Interacts with NIBP; the interaction is direct. Interacts with ARRB1 and ARRB2. Interacts with TRIM21. Interacts with NLRC5; prevents IKBKB phosphorylation and kinase activity. Interacts with PDPK1. Interacts with EIF2AK2/PKR. The phosphorylated form interacts with PPM1A and PPM1B. Interacts with ZNF268 isoform 2; the interaction is further increased in a TNF-alpha-dependent manner. Interacts with IKBKE. Interacts with NAA10, leading to NAA10 degradation. Interacts with FOXO3. Interacts with AKAP13. Interacts with IFIT5; the interaction synergizes the recruitment of IKK to MAP3K7 and enhances IKK phosphorylation. Interacts with LRRC14; disrupts IKBKB-IKBKG interaction preventing I-kappa-B-kinase (IKK) core complex formation and leading to a decrease of IKBKB phosphorylation and NF-kappaB activation. Interacts with SASH1. Interacts with ARFIP2.

(Microbial infection) Interacts with Yersinia yopJ.

(Microbial infection) Interacts with vaccinia virus protein B14.

蛋白家族:

The kinase domain is located in the N-terminal region. The leucine zipper is important to allow homo- and hetero-dimerization. At the C-terminal region is located the region responsible for the interaction with NEMO/IKBKG.

Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. I-kappa-B kinase subfamily.

研究领域

· Cellular Processes > Cell growth and death > Apoptosis.   (View pathway)

· Environmental Information Processing > Signal transduction > MAPK signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > Ras signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > NF-kappa B signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > FoxO signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > mTOR signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > PI3K-Akt signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > TNF signaling pathway.   (View pathway)

· Human Diseases > Drug resistance: Antineoplastic > Antifolate resistance.

· Human Diseases > Endocrine and metabolic diseases > Type II diabetes mellitus.

· Human Diseases > Endocrine and metabolic diseases > Insulin resistance.

· Human Diseases > Endocrine and metabolic diseases > Non-alcoholic fatty liver disease (NAFLD).

· Human Diseases > Infectious diseases: Bacterial > Epithelial cell signaling in Helicobacter pylori infection.

· Human Diseases > Infectious diseases: Bacterial > Shigellosis.

· Human Diseases > Infectious diseases: Parasitic > Chagas disease (American trypanosomiasis).

· Human Diseases > Infectious diseases: Parasitic > Toxoplasmosis.

· Human Diseases > Infectious diseases: Viral > Hepatitis C.

· Human Diseases > Infectious diseases: Viral > Hepatitis B.

· Human Diseases > Infectious diseases: Viral > Influenza A.

· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.

· Human Diseases > Infectious diseases: Viral > HTLV-I infection.

· Human Diseases > Infectious diseases: Viral > Herpes simplex infection.

· Human Diseases > Infectious diseases: Viral > Epstein-Barr virus infection.

· Human Diseases > Cancers: Overview > Pathways in cancer.   (View pathway)

· Human Diseases > Cancers: Overview > MicroRNAs in cancer.

· Human Diseases > Cancers: Specific types > Pancreatic cancer.   (View pathway)

· Human Diseases > Cancers: Specific types > Prostate cancer.   (View pathway)

· Human Diseases > Cancers: Specific types > Chronic myeloid leukemia.   (View pathway)

· Human Diseases > Cancers: Specific types > Acute myeloid leukemia.   (View pathway)

· Human Diseases > Cancers: Specific types > Small cell lung cancer.   (View pathway)

· Organismal Systems > Immune system > Chemokine signaling pathway.   (View pathway)

· Organismal Systems > Development > Osteoclast differentiation.   (View pathway)

· Organismal Systems > Immune system > Toll-like receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > NOD-like receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > RIG-I-like receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > Cytosolic DNA-sensing pathway.   (View pathway)

· Organismal Systems > Immune system > IL-17 signaling pathway.   (View pathway)

· Organismal Systems > Immune system > Th1 and Th2 cell differentiation.   (View pathway)

· Organismal Systems > Immune system > Th17 cell differentiation.   (View pathway)

· Organismal Systems > Immune system > T cell receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > B cell receptor signaling pathway.   (View pathway)

· Organismal Systems > Nervous system > Neurotrophin signaling pathway.   (View pathway)

· Organismal Systems > Endocrine system > Insulin signaling pathway.   (View pathway)

· Organismal Systems > Endocrine system > Adipocytokine signaling pathway.

文献引用

1). Nr2e1 deficiency aggravates insulin resistance and chronic inflammation of visceral adipose tissues in a diet-induced obese mice model. LIFE SCIENCES, 2021 (PubMed: 33915130) [IF=6.1]

Application: WB    Species: mice    Sample: adipose tissues

Fig. 5. Nr2e1 deficiency exacerbated inflammation in EAT. Comparison of the epididymal fat weight (A). The ratio of epididymal fat weight to the total body weight (B). The mRNA expression of F4/80 (C). The mRNA and protein expressions of IL-6, IL-1β, TNF-α and MCP-1 (E, F). The protein levels of p-IKKβ/IKKβ, p-P65/P65 (G, H). The data are expressed as means ± SEM. *P < 0.05, **P < 0.01. ns: not significant.

2). Potential “Therapeutic” Effects of Tocotrienol-Rich Fraction (TRF) and Carotene “Against” Bleomycin-Induced Pulmonary Fibrosis in Rats via TGF-β/Smad, PI3K/Akt/mTOR and NF-κB Signaling Pathways. Nutrients, 2022 (PubMed: 35268069) [IF=5.9]

Application: WB    Species: Rat    Sample:

Figure 8 TRF and carotene protected against pulmonary fibrosis via the inhibition of the NF-κB signaling pathway: (a–d) TRF and carotene decreased the expression of fibrosis proteins induced by BLM in SD rats. The protein expressions of (b) p-p65, (c) p-IkBα, and (d) Ikkβ in lung samples were examined by Western blotting analysis, n = 3; (e–j) representative statistical analyses of (e) TNF-α, (f) IFN-γ, (g) IL-13, (h) NF-κB, (i) IkBα, and (j) Ikkβ mRNA by RT-qPCR, n = 3. Note: compared with CON group, # represents p < 0.05; compared with MOD group, * represents p < 0.05.

3). Tocotrienol-Rich Fractions Offer Potential to Suppress Pulmonary Fibrosis Progression. International Journal of Molecular Sciences, 2022 (PubMed: 36430808) [IF=5.6]

Application: WB    Species: Rat    Sample: lung

Figure 11 PF was protected by TRF via the inhibition of the NF-κB signaling pathway: (a–d) The expression of fibrosis proteins induced by BLM in SD rats was decreased; protein expressions of p-IkBα (b), Ikkβ (c) and p-p65 (d) in lung samples were examined by WB analysis; n = 3. (e–j) Representative statistical analyses of TNF-α (e), IFN-γ (f), IL-13 (g), IkBα (h), NF-κB (i) and Ikkβ (j) in mRNA by RT-qPCR; n = 3. Note: * represents p < 0.05 in comparison to the control group; # represents p < 0.05 in comparison to the model group.

4). Anti-Inflammatory Effects of Huangqin Decoction on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice Through Regulation of the Gut Microbiota and Suppression of the Ras-PI3K-Akt-HIF-1α and NF-κB Pathways. Frontiers in Pharmacology, 2020 (PubMed: 32038240) [IF=5.6]

Application: WB    Species: mouse    Sample: colorectal

FIGURE 7 | Effects of Huangqin decoction (HQD) on colonic expression levels of nuclear factor-kappa B (NF-kB) pathway proteins assessed by Western blot in dextran sulfate sodium (DSS)-induced colitis mice (A).

5). Mechanism of Astragalus mongholicus Bunge ameliorating cerebral ischemia-reperfusion injury: Based on network pharmacology analysis and experimental verification. Journal of ethnopharmacology, 2024 (PubMed: 38588987) [IF=5.4]

6). Caveolin-1 aggravates neurological deficits by activating neuroinflammation following experimental intracerebral hemorrhage in rats. Experimental Neurology, 2023 (PubMed: 37598879) [IF=5.3]

7). Discovery of a doublecortin-like kinase 1 inhibitor to prevent inflammatory responses in acute lung injury. Bioorganic chemistry, 2024 (PubMed: 38394920) [IF=5.1]

8). Nr2e1 ablation impairs liver glucolipid metabolism and induces inflammation, high-fat diets amplify the damage. Biomedicine & Pharmacotherapy, 2019 (PubMed: 31590127) [IF=4.8]

Application: WB    Species: mouse    Sample: liver

Fig. 5. |Nr2e1 ablation induced hepatic inflammation, the change was aggravated by HFD treatment.The expressions of phosphorylated protein of IKKβ, P65, IκBα in liver samples from the four groups were detected by western blots (n = 3) (5A).

9). Magnolol protects against acute gastrointestinal injury in sepsis by down-regulating regulated on activation, normal T-cell expressed and secreted. World Journal of Clinical Cases, 2021 (PubMed: 35004977) [IF=1.1]

Application: WB    Species: Human    Sample: Caco2 cells

Figure 4 Nuclear factor-kappa B pathway-related protein expression and p65 nucleation in Caco2 cells in each group. A: The cells were treated with magnolol or solvent for 8 h and then with lipopolysaccharide (LPS) (100 μg/mL) for 24 h. The protein levels of phosphorylated inhibitor of nuclear factor kappa-B kinase β and p65 were assessed by Western blot; B: Fluorescence distribution of p65 in the nucleus of Caco2cells treated with magnolol or solvent for 8 h and then with LPS (100 μg/mL) for 24 h. Control or Solvent: Treated with solvent only; 10 μmol/L magnolol: Treated with 10 μmol/L concentration of magnolol; LPS: Treated with solvent and LPS (100 μg/mL); LPS + magnolol 10 μmol/L: Treated with magnolol 10 μmol/L and with LPS (100 μg/mL); GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; DAPI: 4,6-guanidine-2-phenylindole; IKKβ: Inhibitor of nuclear factor kappa-B kinase β; p-IKKβ: Phosphorylated inhibitor of nuclear factor kappa-B kinase β; IκBα: Inhibitor of nuclear factor kappa-B kinase α; LPS: Lipopolysaccharide.

10). NP-1 Reverses Left Ventricular Remodeling in Hypertension through Inhibiting NF-KB Signaling Pathway. , 2023

加载更多

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.